Atlas Trials

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

Clinical trial NCT03121820 · COMPLETED

Trial details

NCT number
NCT03121820
Sponsor
Geropharm
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence, AUC, Cmax, Pharmacokinetics
Start date
2016-10-11
Primary completion
2016-11-19
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.